logo
  

Honest Company Posts Adj. EBITDA Loss In Q2; Stock Down

The Honest Company (HNST) reported its seventh consecutive quarter of year-over-year revenue and volume growth. However, the company's adjusted loss per share for the quarter came in below analysts' estimate. Looking forward, the company said it continues to have confidence in its three year strategic plan, Strategy 2023.

On a non-GAAP basis, loss per share was $0.23 for the second quarter of 2021. On average, nine analysts polled by Thomson Reuters expected the company to report a loss per share of $0.14, for the quarter. Analysts' estimates typically exclude special items. Adjusted EBITDA was a loss of $0.8 million for the second quarter of 2021 compared to a gain of $3.5 million during the second quarter of 2020.

Second quarter net loss was $20.0 million, compared to net loss of $0.4 million, a year ago. Net loss per share was $0.17 compared to a loss of $0.01.

Second quarter revenue grew 3% to $74.58 million from $72.35 million, prior year. Excluding an estimated $3.7 million COVID-19 stock-up impact primarily in Diapers and Wipes in the prior year period, revenue growth was 9%, for the quarter. Analysts expected revenue of $79.52 million, for the quarter.

The company ended the second quarter of 2021 with $95.1 million in cash, cash equivalents and short-term investments.

Shares of Honest Company were down nearly 7% in pre-market trade on Friday.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Alexander & Hornung, a business unit of Perdue Premium Meat Co., Inc., is recalling around 234,391 pounds of fully cooked pork products citing possible contamination with Listeria monocytogenes, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves ham and pepperoni products that come under various brands and produced on various dates. Sandoz, Inc., an unit of Novartis AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high temperatures that may have impacted product effectiveness, the U.S. Food and Drug Administration or FDA said in a statement. Livia Global, Inc., a health and wellness company, is recalling two lots of its Liviaone liquid probiotics citing the possibility of contamination by Pseudomonas aeruginosa, the U.S. Food and Drug Administration said. Pseudomonas aeruginosa is a microorganism found in the environment that, if ingested, can cause life-threatening infection in immunocompromised individuals.
Follow RTT